A federal jury found Amgen liable for violating antitrust and tort laws. Elsewhere, Allogene and Kyverna trimmed staff and ...

April 22 (Reuters) - Regeneron Pharmaceuticals (REGN.O), opens new tab said on Tuesday it has signed a deal worth more than $3 billion with contract drug developer Fujifilm Diosynth, potentially ...

Regeneron Pharmaceuticals, Inc. and Society for Science (the Society) announced that Adam Kovalcík, 19, of Dulovce, Slovakia, ...

We recently compiled a list of the 11 Cheap ESG Stocks to Buy According to Hedge Funds. In this article, we are going to take ...

Regeneron earned quarterly profit of $8.22 per share, below estimates of $8.82 according to data compiled by LSEG. U.S. sales of Eylea, jointly developed with Bayer, fell 26% in the first quarter ...